Scarica l'app Stockscreener
0.512
2.48%
-0.013
Dopo l'orario di chiusura:
.52
0.008
+1.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GBIO Giù?
Forum
Previsione
Precedente Chiudi:
$0.525
Aprire:
$0.5223
Volume 24 ore:
265.64K
Relative Volume:
0.54
Capitalizzazione di mercato:
$34.20M
Reddito:
-
Utile/perdita netta:
$-126.61M
Rapporto P/E:
-0.2612
EPS:
-1.96
Flusso di cassa netto:
$-60.14M
1 W Prestazione:
-2.01%
1M Prestazione:
-24.71%
6M Prestazione:
-80.31%
1 anno Prestazione:
-82.93%
Intervallo 1D:
$0.512
$0.5469
Intervallo di 1 settimana:
$0.4721
$0.5469
Portata 52W:
$0.4721
$4.65
Generation Bio Co Stock (GBIO) Company Profile
Nome
Generation Bio Co
Settore
Industria
Telefono
857-529-5908
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Confronta GBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.512 | 34.20M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-10-19 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-07-07 | Iniziato | Jefferies | Buy |
| 2020-07-07 | Iniziato | Wedbush | Outperform |
Mostra tutto
Generation Bio Co Borsa (GBIO) Ultime notizie
Generation Bio earnings missed by $0.02, revenue topped estimates - Investing.com
Generation Bio Co (GBIO) Q4 2024 Earnings: EPS Misses Estimate o - GuruFocus.com
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Generation Bio's Breakthrough: 98% T Cell Success Powers $185M Cash Runway Through 2027 - StockTitan
Generation Bio Co (GBIO)’s stock rises to 0.52 per share - US Post News
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
A Guide To The Risks Of Investing In Generation Bio Co (GBIO) - Knox Daily
Generation Bio stock hits 52-week low at $0.52 - Investing.com
Generation Bio stock hits 52-week low at $0.52 By Investing.com - Investing.com UK
Generation Bio (GBIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Contrasting Generation Bio (NASDAQ:GBIO) & Anthera Pharmaceuticals (OTCMKTS:ANTH) - Defense World
Generation Bio faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Generation Bio faces Nasdaq delisting over share price - Investing.com India
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times
Can Generation Bio's Autoimmune Disease Strategy Transform T Cell Treatment? CEO Reveals Plans - StockTitan
Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance - PR Newswire
Generation Bio stock hits 52-week low at $0.6 amid sharp decline - Investing.com Nigeria
Generation Bio stock hits 52-week low at $0.6 amid sharp decline By Investing.com - Investing.com South Africa
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing - EU-Startups
Generation Bio stock hits 52-week low at $0.66 By Investing.com - Investing.com Nigeria
Generation Bio stock hits 52-week low at $0.66 - MSN
Insider Buying: Quinn Anthony G., Generation Bio Co [GBIO] Director invested 125,791 shares - Knox Daily
BBAI Stock Sees Surge of Approximately 95.33% in Last Five Days - Knox Daily
Insider Selling: Les Jason, Riot Platforms Inc [RIOT] CHIEF EXECUTIVE OFFICER divested 50,000 shares - Knox Daily
Biotech Executive Powerhouse: Ex-Generation Bio CFO Takes Dual Leadership Role at Rising ADC Developer Tubulis - StockTitan
Pioneering the next generation of bio-based polymers in partnership with London-listed Synthomer - University of York
Ratio Revelations: Generation Bio Co (GBIO)’s Financial Metrics in the Spotlight - The Dwinnex
Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat
3 US Penny Stocks With Market Cap Under $70M - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Purchased by Barclays PLC - Defense World
Generation Bio chief scientific officer Matthew Stanton to leave role - MSN
Analysts Provide Insight Into Generation Bio Co’s (GBIO) Potential. - Stocks Register
Will Generation Bio (NASDAQ:GBIO) Spend Its Cash Wisely? - Yahoo Finance
Generation Bio Independent Director Acquires 131% More Stock - Yahoo Finance
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Jane Street Group LLC - Defense World
Hinge Bio Raises $30 Million Series A’ Financing to Develop - GlobeNewswire
Generation Bio director Quinn Anthony buys $203k in shares By Investing.com - Investing.com South Africa
Generation Bio Co. (NASDAQ:GBIO) Director Anthony G. Quinn Purchases 125,791 Shares - MarketBeat
Anthony G. Quinn Purchases 85,000 Shares of Generation Bio Co. (NASDAQ:GBIO) Stock - MarketBeat
Generation Bio Co Azioni (GBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):